This document discusses acute pain management in the emergency department. It begins with an introduction noting that pain is the most common presenting symptom in emergency departments, with over 60% of patients experiencing pain. It then focuses on defining acute pain and providing an overview of the pathophysiology of acute pain. The document also discusses common barriers to pain management in emergency settings, dos and don'ts of pain treatment, and strategies to improve pain management in the emergency department. It provides recommendations from international health organizations on patients' right to pain relief.
Ideal pain clinic
Promoting multidisciplinary team approach
Coordinating all specialist effort
Measuring the outcome of treatment offered
Promoting palliative model rather than curative models of pain treatments
Identifying complications of IPM and promoting safe and base-evidence intervention
Pain definition, Pain pathways, pain modulation, the endorphin system, Types of Pain, current trend of Drugs used for pain management. New Drugs for pain
Ideal pain clinic
Promoting multidisciplinary team approach
Coordinating all specialist effort
Measuring the outcome of treatment offered
Promoting palliative model rather than curative models of pain treatments
Identifying complications of IPM and promoting safe and base-evidence intervention
Pain definition, Pain pathways, pain modulation, the endorphin system, Types of Pain, current trend of Drugs used for pain management. New Drugs for pain
The presentation enhances the reader to get comprehensive view about Pain ( physiology of pain, assessment of pain and Management of pain). This will help you to management pain effectively.
Anatomical difficult airway has been emphasised immensely in poly trauma management . But we very often forgot to look into the correctable physiological airway difficulties ...this presentation is exploring this aspect of airway management .
This session was done in Nepal emergency medicine conference in October 2023 at Kathmandu
This session was done in 2 nd EMS and Industrial Emergency Medicine conference in Ahammadabad in Feb 2020. The presentation explores how to asses the Key Performance in EMS and Ambulance Scenario.
Airway manipulations and intubation are the potential to cause a high level of aerosolization in the emergency department. This presentation is giving an overview of how to perform protected intubation in the emergency department. It has prepared by using the available latest data on COVID 19 protected Intubation
Evidence-based medicine is the cornerstone of quality clinical practice. It is very important that a critical appraisal of a scientific article. This presentation covers a primary survey & Secondary survey approach to select, read and appraise the article
The presentation covers various aspects of DM like the type of disasters, scientific approach, disaster cycle, zones, Incident command, triage, Hospital plan, communication, statutory structure, and support organizations
Prehospital care in trauma is as important as in hospital care. The presentation addresses simple and basic approach to care a polytrauma victim in platinum 10 minutes based on BTLS.
The presentation covers basics of pharmacotherapy involves in advanced life support scenario including peri-arrest situations which have been updated 2019
The presentation covers an easy method to manage acute poisoning in Ed. It elaborates the tox presentations through four toxidromes and an algorithmic approach to solve the puzzle
The presentation covers definitions, identification, Treatment goals, Special situations, Practice points, and cardinal pharmacotherapy. Session presented in NBE learning session
This presentation covers various aspects of OHCA scenarios, including incidence, outcome, challenges, solutions, hen to initiate CPR, protocols, Termination, ECPR, and other issues are covering in details. Explore regional experiences in training and OHCA results as well.
This presentation covers various aspects of OHCA scenarios, including incidence, outcome, challenges, solutions, hen to initiate CPR, protocols, Termination, ECPR, and other issues are covering in details. Explore regional experiences in training and OHCA results as well.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
1. Acute Pain Management in the ED
Dr. Venugopalan P.P. DA, DNB, MNAMS.MEM[GWU-US]
Director ,Emergency Medicine ,Aster-DMHC
Deputy Director ,MIMS Academy ,PG Teacher NBE
Kozhikode , Kerala , India
www.drvenu.blogspot.in
2. Pace 2014,August 2014 -1 to 3rd at
Chennai
Introduction
• Pain is the most common presenting
symptom in emergency departments
• More than 60 percent of ED patients have
pain as their main symptom or a major
part of their symptoms.
3. Introduction…
• Pain is always subjective .
• No test to prove or disprove the patient’s
pain.
• Not vital signs, a patient’s facial expressions,
or “gut instincts” can be used to invalidate a
patient’s rating of his or her pain.
4. Introduction…
• An unrelieved pain has deleterious effects
on “physical, physiological &
psychological” systems.
• Remarkable discomfort to the patients
6. Focus
• Define acute pain
• Brief overview of pathophysiology
• Barriers in pain management in ER settings
• Common Dos & Don'ts
• Common Pitfalls in pain management
• Strategies to improve pain management in ER
• International recommendations
7. Definition
Pain is ‘an unpleasant sensory and
emotional experience associated with
actual or potential tissue damage, or
described in terms of such damage’ or,
more simply, ‘pain is what the patient says
it hurts’
Assessment of acute and chronic pain, www. Anesthesiauk.com
Created: 5/9/2005 ,Updated: 12/1/2009
10. Acute Pain Chronic Pain
Cause Generally
Known
Often unknown
Duration Short -3 to 6
months
Long - more
than 6months
Behaviour Anxiety Depression
Response to
treatment
Well to
medicine
Does not
respond well
Tissue
appearance
Red White
Treatment R.I.C.E
Rest-
Ice-
Compression-
Evaluation
M.E.A.T
Movement-
Exercise-
Analgesic-
Treatment
11. Acute pain
• Injury or Pathologic
condition
• Resolves with inciting cause
• Nociceptors
• Release of chemicals –
leukotrienes, Bradykinins,
Serotonin, Histamine &
Thromboxanes, Substance P
12. Prostaglandins
• Not directly activate receptors
• Act as local mediator
• Increases sensitivity of nerve endings
• Pain and edema
Fink WA Jr, The pathophysiology of acute pain .Emerg Med Clin North
Am. May 2005;23[2]:277-284.[review]
16. “Wind up”
phenomenon
Sharp localized pain
Dull diffused pain
Pain should be treated as early as possible
• Noxious stimuli cause increased
nociceptor responsiveness
• Progressive increase in dorsal horn neuron
output
• Pain amplification
17.
18. When a patient in pain enters the ED he or she has
two main concerns
1.How quickly can I get relief from my pain?
2.What is causing this pain?
19. The major focus of health care professionals
1. What is the
diagnosis?
2. What is the
treatment for the
underlying disease
process?
21. No Pain Worst Pain
Imaginable
Visual
Analogue
Scale
The patient is shown a 10cm line marked as above. They are
asked to put a mark across the line that indicates the severity
of the pain. Doctor or Nurse then measure the distance from
“No pain “ to the mark in cm
22. 0 1 2 3 4 5 6 7 8 9 10
No Pain Worst Pain
Imaginable
Numerical
Analogue
Scale
The patient is shown the scale above. They are
asked to indicate which number equates to the
pain they feel
23. Verbal Rating Scale -VRS
Five pain levels in large print
• No pain
• Mild
• Moderate
• Severe
• Unbearable
25. Pain assessment in children
Wong-Bakers FACES – Pain Rating Scale
Hockenberry MJ: Essentials of pediatric Nursing ed 7,st,Louis ,2005 ,Mosby
P 1301
26. CHOEPS
Children’s Hospital of Eastern Ontario Pain Scale
• Crying
• Facial expression
• Verbalization
• Activity of Torso
• Touching
• Response of Lower
limbs
Score
Minimum – 4
Maximum - 13
Hennrikus:J Bone Joint Surg Am ,Volume77-A[3] March 1995.335-339
27. PQRST Symptom Analysis
• Presentation , Provocation & Palliative
• Quality – Sharp, Dull ,Pricking ,colicky etc
• Radiation, Region and Relieving factors
• Severity – Pain Scale
• Time of onset and Treatment received
32. OPIOIDS regularly
Paracetamol 1gm orally or rectally /regularly q. d.. s
Severe pain
Moderate pain
Mild pain
OPIOIDS when required
Non steroidal anti inflammatory drugs
0 3 6
10
No Pain Moderate pain
Worst
Possible pain
Acute pain relief
Treatment
Chart
33.
34. Mild pain
1-3
Paracetamol p.o
Ibuprofen p.o
Moderate pain 4-6
As for mild pain
+
NSAIDS p.o
or
Tramadol p.o
Severe pain 7-10
Entonox initially
or
IV morphine Titrated
Dose
Supplimented with
NSAIDS
or
Ketamine
Assess pain severity
Use Splints/Slings/ Dressings
Consider the other causes
Consider regional blocks
Acute pain treatment algorithm
35.
36.
37. Pain score
Initial Dose
Monitor
Pain score
Top up
dose
Monitor
Pain score
Top up
Pain Free
Morphine 3 mg - 1mg - 1mg - repeat till get zero pain score
Fentanyl 30 mcg - 10 mcg -10 mcg- repeat till get zero pain score
Ketamine 20 mg - 5 mg - 5 mg - 5 mg repeat as needed
Titrate ….No calculated dose
Pentazocine- Ceiling effect , Tachycardia , Hypertension
38.
39. Tramadol
• Believe as safe
• Not so potent as we
think
• Convulsion
• Restlessness in Aged
• Cardio respiratory
arrest
43. Nerve block
• Pivotal role in acute pain
management
• Reduce NSAID and Opioid use
• Very effective and get Zero pain
score
• Need skill updation
• USG made revolution in Nerve block
• Assess and document neurological
status
• Highly recommended in devastating
injuries
51.
Evidences
• Patients presenting to an ED with a
complaint of pain, two-thirds never had
an assessment of their pain documented.
Todd KH et al. The Joint Commission on Accreditation of Healthcare
Organizations Pain Initiative: Are We Meeting the Standard?
Annals of Emergency Medicine. 2000. 36:4 S68
52. Evidences…
• Of these patients, only one-third ever had
a re-assessment of their pain
• Upon discharge from the ED, 43 percent
of patients were still in moderate or
severe pain
Todd KH et al. The Joint Commission on Accreditation of Healthcare
Organizations Pain Initiative: Are We Meeting the Standard?
Annals of Emergency Medicine. 2000. 36:4 S68
53. Evidences
• Reviewed 198 patients admitted to ED
with acute pain
• 67% had documentation
• 44% received narcotics
• 60% received intramuscular doses
Wilson JE et al .Oligoanalgesia in the emergency department .An J Emerg
Med .Nov1989;7[6]:620-623[Review 198 patients]
54. Evidences…
• 33% of the documented cases received
suboptimal analgesia
• 69% waited more than one hour to get
analgesics
• 42% waited more than 2 hours.
Wilson JE et al .Oligoanalgesia in the emergency department .An J Emerg
Med .Nov1989;7[6]:620-623[Review 198 patients]
55. Evidences…
• 842 patients at 20 US Canadian hospital participated in
study to assess the current state of ED pain
management.
• Patients presented with a median NRS of 8
Knox H .Todd; Acute pain in the emergency room setting : An expert interview;
Medscape neurology & neurosurgery 05/27/2008;www.medscape.com
56. Evidences…
• 41% - no change in the pain score in ED
• 34% -discharged without any change in
pain score
• 45% patients discharged with NRS 4-7 and
29% patients with NRS 8-10.
Knox H .Todd; Acute pain in the emergency room setting : An expert interview;
Medscape neurology & neurosurgery 05/27/2008;www.medscape.com
57. • Under assessed
•Under managed
Emergency
Department
ANZCA .statement on pateints’ rights to pain management .ANZCA
ps 45;2001,available at www.anzca.edu.au
Acute Pain- The “ TRUTH”
• The Fifth Vital sign
• Relief from pain is a “Fundamental Right”
“Declaration of Montreal”2010
58. Related
Health Care system
Health Care provider
Patient
Agency for Healthcare Research and Quality .[2005] Management of
cancer symptoms :Pain, depression and fatigue .www.ahrq.gov/downlods/pub/
evidence
Pain
B
A
R
R
I
E
R
S
Emergency Department
59. Martin D et al .Barriers to pain management in emergency department ;
emergency nurse ,vol 15 no 9, feb 2008. 30-34;
Healthcare system related
• Lack of time
• ED overcrowding
• Poor levels of clinician education
• Inadequate policy and standards
• Suboptimal use of analgesics
60. Healthcare provider related barriers
• Subjective nature of pain
• Attitude
• Beliefs
• Poor understandings / false beliefs on
using opiates like morphine
World Health Organization [1986]Cancer pain relief .WHO. Geneva
61. Patient related barriers
• Misconceptions
• Society’s traditional views
• Fear of consequences
• Fatalism
• Communication fear
• Alcohol and drugsMartin D et al .Barriers to pain management in emergency department ;
emergency nurse ,vol 15 no 9, feb 2008. 30-34;
62. 10 dos 10 donts
10
Pitfalls
Acute Pain management
64. Ten Do’s Ten Don’ts
Ten’s ‘N’ Acute Pain
P
A
I
N
65. Acute Pain – 10 – Do’s
1. Believe the patient’s assessment of pain
2. Give adequate doses of analgesics [ED & Disposal] and
document the patient’s response
3. Prevent pain before it begins
4. Treat aggressively
Titrate ...Titrate… Titrate…
66. Acute Pain – 10 – Do’s…
5. Opioids are very useful in both acute and
chronic pain*
6. Anticipate side effects
7. Treat by the clock
*Consensus statement ,the American Pain Society and the American
Academy of Pain Management statement .Clinical journal of Pain .
1997.Mar.13[1]:6-8
67. Acute Pain – 10 – Do’s…
8.Write prescriptions wisely
[Quantity & Strength in both Letters and Numbers]
9.Refer patients appropriately to primary care provider or
pain clinician
10.Prescribe Patient Controlled Analgesia [PCA]
68. Acute Pain – 10 – Don’ts
1. Intramuscular
injections
2. Meperidine
3. Sedative or anti-
emetic along with
analgesics
4. Term ‘Narcotics’
Avoid…Avoid ..Avoid
69. Acute Pain – 10 – Don’ts…
5. Codeine - Very weak
opioids
6. Propoxyphene – Very
weak analgesic
7. Treating acute and
chronic pain in the same
pace
8. Prescribing PRN schedule
Avoid …Avoid…Avoid
70.
71. Acute Pain – 10 – Don’ts…
9. Holding Opioids due
to fear
10.Holding pain
treatment to reach a
diagnosis.
No need a ‘Diagnosis’
to control pain
Silen W. Cope’s Early Diagnosis of the Acute Abdomen.2000
73. 2nd Eurasian International Congress on Emergency Medicine 28th – 31st Nov 2008 at Antalya Turkey
Acute Pain- 10 – Pitfalls
• “The patient had abdominal pain , But I didn't give any pain
medication because I did not want to mask the exam”
1.Comfortable patient yields more information
2.Pain relief will not mask serious pathology
Emergency medicine practice :An evidence based approach to emergency
Medicine .EBMedPractice.net; July 2006;8[7].
One
74. 2nd Eurasian International Congress on Emergency Medicine 28th – 31st Nov 2008 at Antalya Turkey
Acute Pain- 10 – Pitfalls..
• “The vital signs were normal , so even though he said he was
in pain there wasn't any evidence that it was true.”
1.Vital signs are not a reliable predictor of pain
severity
2.Patient’s version is most reliable
Emergency medicine practice :An evidence based approach to emergency
Medicine .EBMedPractice.net; July 2006;8[7].
Two
75. 2nd Eurasian International Congress on Emergency Medicine 28th – 31st Nov 2008 at Antalya Turkey
Acute Pain- 10 – Pitfalls..
• “I didn’t give narcotics because I was afraid he would get
addicted”
No evidence to support acute pain management causes
narcotic addiction
Emergency medicine practice :An evidence based approach to emergency
Medicine .EBMedPractice.net; July 2006;8[7].
Three
76. 2nd Eurasian International Congress on Emergency Medicine 28th – 31st Nov 2008 at Antalya Turkey
Acute Pain- 10 – Pitfalls..
• “The patient was not in pain at the time of discharge, so pain
control did not need to be addressed”
1.Patient should be discharged with pain killers
2.Some disease process may increase after discharge
to cause pain
Emergency medicine practice :An evidence based approach to emergency
Medicine .EBMedPractice.net; July 2006;8[7].
Four
77. 2nd Eurasian International Congress on Emergency Medicine 28th – 31st Nov 2008 at Antalya Turkey
Acute Pain- 10 – Pitfalls..
• “Patient was an IV drug abuser; I knew he was just looking for
pain medication, so I sent him right out”
Emergency medicine practice :An evidence based approach to emergency
Medicine .EBMedPractice.net; July 2006;8[7].
1.IV drug abusers at risk for complications like epidural
abscess , necrotizing fascitis etc.
2.Need proper ED evaluation
F
I
V
E
78. 2nd Eurasian International Congress on Emergency Medicine 28th – 31st Nov 2008 at Antalya Turkey
Acute Pain- 10 – Pitfalls..
• “The parents did not think the child was in pain, so I stopped
thinking about pain control at that point”
1.Parents may underestimate pain
2.Look for signs – grimace, guarding etc
3.Child’s pain is serious
Emergency medicine practice :An evidence based approach to emergency
Medicine .EBMedPractice.net; July 2006;8[7].
S
I
X
79. 2nd Eurasian International Congress on Emergency Medicine 28th – 31st Nov 2008 at Antalya Turkey
Acute Pain- 10 – Pitfalls..
• “She was an IV drug abuser, so I gave her pain meds I would
have given anyone else. When pain wasn't controlled I told her
that was her problem”
1.Tolerance to opiates may need more medications
2.Actual dose should not be the primary concern
S
E
V
E
N
80. 2nd Eurasian International Congress on Emergency Medicine 28th – 31st Nov 2008 at Antalya Turkey
Acute Pain- 10 – Pitfalls..
• “I made the diagnosis, which is my priority. What difference
does it make if I treated their pain?”
1.Stabilizing patient’s pain should also be in the priority
2.No need a diagnosis to initiate pain meds
E
I
G
H
T
81. 2nd Eurasian International Congress on Emergency Medicine 28th – 31st Nov 2008 at Antalya Turkey
Acute Pain- 10 – Pitfalls..
• “The patient was too demented to even know if he was in
pain, he didn’t need medication”
Non verbal patients may be in significant pain.
ED physicians should be attuned to other signs
N
I
N
E
82. 2nd Eurasian International Congress on Emergency Medicine 28th – 31st Nov 2008 at Antalya Turkey
Acute Pain- 10 – Pitfalls..
• “She was allergic to everything but meperidine, that’s when I
knew she was a drug- seeker”
1.When patients list allergies , physician should
explore what is meant
2.Should evaluate pathology and need for pain meds.
T
E
N
83. Acute Pain –Strategies
1. Prioritise pain
management
2. Mandatory pain
assessments
3. Ongoing education-
Patients & Clinicians
4. Ongoing evaluation of
strategies Rupp T et al , Inadequate analgesia in the emergency medicine. Annals of
Emergency medicine 2004;43,4,494-503
85. International guidelines
Pain assessment
standards
[ Joint Commission on
Accreditation of
Health Care
Organizations –
JCAHCO 2001] USA
JCAHO 2001.Revised pain management standards.www.jointcommission.
org/standards/
86. International guidelines…
Musculoskeletal pain
management guidelines
[National Health and
Medical Research Council
-2003 ]-Australia
Evidence- based management of acute musculoskeletal pain .
www.nhmrc.gov/publications/ synopses/_files/cp94.pdf. 2003
87. International guidelines…
Recent guidelines
[British Association for
Accident and Emergency
Medicine -2007] UK
Clinical effectiveness committee audit standards for Emergency Departments.
www.emergencymed.org.uk/BAEM/CEC/assets/summory_of_standards_Jan
2007.
88.
89.
90.
91.
92. Conclusion
Relieving from pain is the fundamental
right of the patients.
Physician’s lacunae should not end up in
under treated pain .